U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Type II Endometrial Adenocarcinoma

MedGen UID:
276911
•Concept ID:
C1519714
•
Neoplastic Process

Definition

A classification of primary endometrial adenocarcinomas that refers to clear cell adenocarcinoma, serous adenocarcinoma, and serous endometrial intraepithelial carcinoma. [from NCI]

Professional guidelines

PubMed

Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women.
Mahdi H, Hou H, Kowk LL, Moslemi-Kebria M, Michener C
Gynecol Oncol 2014 Jun;133(3):512-7. Epub 2014 Mar 24 doi: 10.1016/j.ygyno.2014.03.562. PMID: 24674830

Recent clinical studies

Etiology

Histologic and immunohistochemical analyses of endometrial carcinomas: experiences from endometrial biopsies in 358 consultation cases.
Wei JJ, Paintal A, Keh P
Arch Pathol Lab Med 2013 Nov;137(11):1574-83. doi: 10.5858/arpa.2012-0445-OA. PMID: 24168495
Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
Pansare V, Munkarah AR, Schimp V, Haitham Arabi M, Saed GM, Morris RT, Ali-Fehmi R
Mod Pathol 2007 Jan;20(1):35-43. Epub 2006 Nov 10 doi: 10.1038/modpathol.3800718. PMID: 17099695

Diagnosis

Histologic and immunohistochemical analyses of endometrial carcinomas: experiences from endometrial biopsies in 358 consultation cases.
Wei JJ, Paintal A, Keh P
Arch Pathol Lab Med 2013 Nov;137(11):1574-83. doi: 10.5858/arpa.2012-0445-OA. PMID: 24168495
Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
Pansare V, Munkarah AR, Schimp V, Haitham Arabi M, Saed GM, Morris RT, Ali-Fehmi R
Mod Pathol 2007 Jan;20(1):35-43. Epub 2006 Nov 10 doi: 10.1038/modpathol.3800718. PMID: 17099695
Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G, Németh J, Kiss A, Lotz G, Szabó I, Udvarhelyi N, Schaff Z, Páska C
Gynecol Oncol 2006 Nov;103(2):591-8. Epub 2006 Jun 22 doi: 10.1016/j.ygyno.2006.04.005. PMID: 16797678

Prognosis

Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
Pansare V, Munkarah AR, Schimp V, Haitham Arabi M, Saed GM, Morris RT, Ali-Fehmi R
Mod Pathol 2007 Jan;20(1):35-43. Epub 2006 Nov 10 doi: 10.1038/modpathol.3800718. PMID: 17099695
Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G, Németh J, Kiss A, Lotz G, Szabó I, Udvarhelyi N, Schaff Z, Páska C
Gynecol Oncol 2006 Nov;103(2):591-8. Epub 2006 Jun 22 doi: 10.1016/j.ygyno.2006.04.005. PMID: 16797678

Clinical prediction guides

Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas.
Pansare V, Munkarah AR, Schimp V, Haitham Arabi M, Saed GM, Morris RT, Ali-Fehmi R
Mod Pathol 2007 Jan;20(1):35-43. Epub 2006 Nov 10 doi: 10.1038/modpathol.3800718. PMID: 17099695
Claudin 1 differentiates endometrioid and serous papillary endometrial adenocarcinoma.
Sobel G, Németh J, Kiss A, Lotz G, Szabó I, Udvarhelyi N, Schaff Z, Páska C
Gynecol Oncol 2006 Nov;103(2):591-8. Epub 2006 Jun 22 doi: 10.1016/j.ygyno.2006.04.005. PMID: 16797678

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...